| Dataset | DGIdb Drug Targets 2026 |
| Category | physical interactions |
| Type | drug |
| Description | A C-glycosyl compound that is used (in its hemihydrate form) for treatment of type II diabetes via inhibition of sodium-glucose transport protein subtype 2. (Chemical Entities of Biological Interest Ontology, CHEBI_73274) |
| External Link | https://dgidb.org/results?searchType=drug&searchTerms=CANAGLIFLOZIN |
| Similar Terms | |
| Downloads & Tools |
3 interacting proteins for the CANAGLIFLOZIN drug from theDGIdb Drug Targets 2026 dataset.
